Corporate News     22-May-23
Board of Godawari Power & Ispat recommends Final Dividend
Of Rs.4 per share
Godawari Power & Ispat announced that the Board of Directors of the Company at its meeting held on 20 May 2023, has recommended a Final dividend of Rs.4 per share (i.e.80%), subject to the approval of the shareholders.
Previous News
  Godawari Power & Ispat consolidated net profit rises 1.35% in the March 2025 quarter
 ( Results - Announcements 21-May-25   07:37 )
  Godawari Power hits life high as board OKs Rs 301 cr share buyback
 ( Hot Pursuit - 18-Jun-24   10:07 )
  Godawari Power & Ispat consolidated net profit rises 104.32% in the December 2021 quarter
 ( Results - Announcements 01-Feb-22   08:03 )
  Godawari Power & Ispat allots 2.84 lakh equity shares under ESOP
 ( Corporate News - 25-Apr-25   18:57 )
  Godawari Power & Ispat schedules AGM
 ( Corporate News - 07-Aug-24   16:34 )
  Godawari Power & Ispat EGM scheduled
 ( Corporate News - 07-Nov-23   16:37 )
  Volumes jump at Godawari Power & Ispat Ltd counter
 ( Hot Pursuit - 08-Oct-24   14:30 )
  Godawari Power & Ispat consolidated net profit declines 43.20% in the September 2022 quarter
 ( Results - Announcements 10-Nov-22   16:25 )
  Godawari Power & Ispat receives revision in credit ratings
 ( Corporate News - 14-Dec-22   16:43 )
  Godawari Power & Ispat consolidated net profit declines 6.32% in the June 2019 quarter
 ( Results - Announcements 10-Aug-19   16:36 )
  Godawari Power & Ispat announces board meeting date
 ( Corporate News - 12-May-23   09:59 )
Other Stories
  LMW schedules board meeting
  03-Jul-25   09:15
  Julien Agro Infratech announces board meeting date
  03-Jul-25   09:15
  Alembic Pharmaceuticals announces acquisition of Utility Therapeutics
  03-Jul-25   09:15
  Shriram Asset Mgt. Company schedules AGM
  03-Jul-25   09:14
  Ideaforge Technology to convene AGM
  03-Jul-25   09:14
  D-Link (India) to announce Quarterly Result
  03-Jul-25   09:14
  Tuni Textile Mills to conduct board meeting
  03-Jul-25   09:14
  Biocon Biologics receives EU marketing authorisation for Vevzuo® and Evfraxy® biosimilars of Denosumab
  03-Jul-25   09:12
  Shakti Pumps launches QIP issue
  03-Jul-25   09:08
  Jai Mata Glass to conduct board meeting
  02-Jul-25   19:12
Back Top